Cardura
doxazosin
- Strength
- 8 mg/1
- Form
- Tablet
- Class
- alpha-Adrenergic Blocker
Viatris Specialty LLC
Cardura
doxazosin
Listed by Viatris Specialty LLC
- Strength
- 2 mg/1
- Form
- Tablet
- Route
- Oral
- Class
- alpha-Adrenergic Blocker
What it contains
- Doxazosin Mesylate 2 mg/1
FDA record
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | alpha-Adrenergic Blocker |
| Approval route | NDA — original brand approval |
| NDC code | 58151-075 |
| FDA application | NDA019668 |
| RxNorm concept | 104367 |
| Marketed since | April 2025 |
Other products containing Doxazosin
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Cardura
doxazosin
- Strength
- 4 mg/1
- Form
- Tablet
- Class
- alpha-Adrenergic Blocker
Viatris Specialty LLC
Cardura
doxazosin
- Strength
- 1 mg/1
- Form
- Tablet
- Class
- alpha-Adrenergic Blocker
Viatris Specialty LLC
Cardura
doxazosin
- Strength
- 4 mg/1
- Form
- Tablet
- Class
- alpha-Adrenergic Blocker
ROERIG
Cardura
doxazosin
- Strength
- 8 mg/1
- Form
- Tablet
- Class
- alpha-Adrenergic Blocker
ROERIG
Cardura
doxazosin
- Strength
- 2 mg/1
- Form
- Tablet
- Class
- alpha-Adrenergic Blocker
ROERIG
Cardura XL
doxazosin mesylate
- Strength
- 4 mg/1
- Form
- Tablet, Film Coated, Extended Release
- Class
- alpha-Adrenergic Blocker
Viatris Specialty LLC
Cardura XL
doxazosin mesylate
- Strength
- 8 mg/1
- Form
- Tablet, Film Coated, Extended Release
- Class
- alpha-Adrenergic Blocker
Viatris Specialty LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.